Learn to interpret insider stock sales like Tesla's recent $118M selloff. Discover the key differences between planned 10b5-1 ...

A former pharmaceutical executive traded on nonpublic information about an antipsychotic drug’s development, avoiding $1.3 ...

Demos, a medical doctor who was the Vice President of Drug Safety and Pharmacovigilance and member of the drug label team at ...

George Demos, 64, formerly of Acadia Pharmaceuticals Inc., admitted selling more than 60,000 company shares just before news broke regarding an issue with one of the company's products ...

VP at Acadia Pharmaceuticals, pled guilty to insider trading, avoiding a $1.3M loss by illicitly selling shares ahead of a negative FDA news impact. He faces sentencing in May 2025.

Sebi has issued a cautionary letter to Nestle India over alleged insider trading violated by a high-ranking official. Nestle reassures that this incident will not hinder its financial and ...

The former CEO of Acadia Pharmaceuticals Inc., headquartered in Sorrento Valley, pleaded guilty Friday to insider trading.

On Wednesday, state officials joined local leaders and private sector partners to celebrate the groundbreaking of Pacific ...

Nestle India said on Friday (March 7, 2025) it received a warning from the country’s markets regulator for a breach of insider trading regulations “by a designated person of the company”.